Cargando…
Mucormycosis during Imatinib treatment: case report
Philadelphia chromosome positive acute lymphoblastic leukemia is classified as a very high-risk group and it requires an intensive chemotherapy regimen associated with tyrosine-kinase inhibitors and allogeneic hematopoietic stem cell transplant from related or unrelated HLA matched donor. Most times...
Autores principales: | Crisan, AM, Ghiaur, A, Stancioaca, MC, Bardas, A, Ghita, C, Manea, CM, Ionescu, B, Coriu, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556922/ https://www.ncbi.nlm.nih.gov/pubmed/26351543 |
Ejemplares similares
-
The impact of additional cytogenetic abnormalities at
diagnosis and during therapy with tyrosine kinase
inhibitors in Chronic Myeloid Leukaemia
por: Crisan, AM, et al.
Publicado: (2015) -
Successful treatment of pulmonary haemorrhage and acute respiratory distress syndrome caused by fulminant Stenotrophomonas maltophilia respiratory infection in a patient with acute lymphoblastic leukaemia – case report
por: Andrei, Stefan, et al.
Publicado: (2020) -
The Difficult-to-Treat del 17 p Patient—A Case Report in Chronic Lymphocytic Leukemia
por: Moldovianu, Ana-Maria, et al.
Publicado: (2021) -
The simultaneous occurrence of multiple myeloma and JAK2 positive myeloproliferative neoplasms - Report on two cases
por: Badelita, S, et al.
Publicado: (2015) -
Dasatinib/imatinib: Treatment failure: case report
Publicado: (2022)